Article
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 Mutation.
Clinical lung cancer - 1 Mar 2022
Pinquie François, Cortot Alexis B, Chevalier Louise-Marie, Morel Alain, Sandrini Jérémy, Guguen Camille, Morvan Benjamin, Molinier Olivier
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.